TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharmor AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,682
|
2,980
|
2,796 |
| Financial expenses |
317
|
437
|
585 |
| Earnings before taxes |
1,605
|
924
|
1,095 |
| EBITDA |
1,641
|
1,300
|
1,321 |
| Total assets |
5,784
|
4,561
|
3,793 |
| Current assets |
1,468
|
1,898
|
1,589 |
| Current liabilities |
1,015
|
914
|
653 |
| Equity capital |
4,340
|
3,291
|
2,834 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
75.0%
|
72.2%
|
74.7% |
| Turnover per employee |
3,682
|
2,980
|
2,796 |
| Profit as a percentage of turnover |
43.6%
|
31.0%
|
39.2% |
| Return on assets (ROA) |
33.2%
|
29.8%
|
44.3% |
| Current ratio |
144.6%
|
207.7%
|
243.3% |
| Return on equity (ROE) |
37.0%
|
28.1%
|
38.6% |
| Change turnover |
702
|
184
|
474 |
| Change turnover % |
24%
|
7%
|
20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.